Morphological and Functional Changes of The Liver, Heart, And Kidneys in Obesity
DOI:
https://doi.org/10.31149/ijimm.v4i2.2678Keywords:
Obesity, Hepatic Steatosis, Cardiac Remodeling, Renal Dysfunction, Organ Morphology, Metabolic SyndromeAbstract
Obesity is a major global health challenge associated with structural and functional alterations in multiple organs, particularly the liver, heart, and kidneys. This study aimed to evaluate morphological and functional changes in these organs in patients with obesity and to determine their clinical significance. A total of 180 participants were included in the study, comprising 120 patients with obesity and 60 normal-weight controls. Clinical, biochemical, ultrasound, echocardiographic, and laboratory methods were applied. The findings demonstrated significant hepatic steatosis, left ventricular hypertrophy, and early nephropathy changes in obese individuals compared to controls. The results highlight the systemic impact of obesity and emphasize the importance of early diagnostic and preventive strategies.
References
World Health Organization. Obesity and overweight. Geneva: WHO; 2023.
Powell-Wiley T.M., Poirier P., Burke L.E., et al. Obesity and cardiovascular disease: A scientific statement from the American Heart Association. Circulation. 2021;143(21):e984–e1010. doi:10.1161/CIR.0000000000000973
Stefan N., Häring H.U., Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. The Lancet Diabetes & Endocrinology. 2019;7(4):313–324. doi:10.1016/S2213-8587(18)30154-2
Byrne C.D., Targher G. NAFLD as a driver of chronic kidney disease. Journal of Hepatology. 2020;72(4):785–801. doi:10.1016/j.jhep.2019.09.013
Hall J.E., do Carmo J.M., da Silva A.A., Wang Z., Hall M.E. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circulation Research. 2019;124(4): 523–537. doi:10.1161/CIRCRESAHA.118.313897
Kovesdy C.P., Furth S.L., Zoccali C. Obesity and kidney disease: hidden consequences of the epidemic. American Journal of Nephrology. 2017;45(3):283–291. doi:10.1159/000456819
Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. JACC: Heart Failure. 2018;6(10):861–863. doi:10.1016/j.jchf.2018.06.005
Tilg H., Moschen A.R., Roden M. NAFLD and diabetes mellitus. Nature Reviews Gastroenterology & Hepatology. 2017;14(1):32–42. doi:10.1038/nrgastro.2016.147
Bluher M. Obesity: global epidemiology and pathogenesis. Nature Reviews Endocrinology. 2019;15(5):288–298. doi:10.1038/s41574-019-0176-8
Chagnac A., Weinstein T., Herman M., et al. The effects of weight loss on renal function in patients with severe obesity. Journal of the American Society of Nephrology. 2003;14(6):1480–1486.
